3 results
Approved WMORecruiting
Primary Part 1:-To evaluate ORR in participants treated with MK-4280A plus EV (Arm A), MK-7684A plus EV (Arm B), and pembrolizumab plus EV(Arm C) per RECIST 1.1 by BICR.- To evaluate the safety and tolerability in participants treated with MK-4280A…
Approved WMOPending
The objective of this clinical study is to prove the safety of the CorNeat KPro.
Approved WMORecruiting
Primary Objective:To examine the effect of ORIF versus nonoperative treatment of multiple simple fractured ribs on the rate of pneumonia within 30 days after trauma, in adult patients who sustained multiple simple fractured ribs.Secondary Objectives…